Trial intelligence / Profile preview

Nefopam for postoperative pain after VATS

NCT04450355Completed

Sponsor
Seoul National University Hospital
Start
Jul 2020
Primary completion
Aug 2021
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of nefopam in postoperative pain, sponsored by Seoul National University Hospital. Primary endpoint: Total fentanyl consumption during 24 hours. Started Jul 2020; status: completed.

02

Drugs

nefopam
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04450355.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04450355.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call